Crossmark

Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership – a qualitative study of policy actors’ views

Crossref DOI link: https://doi.org/10.1186/s12992-021-00721-4

Published Online: 2021-07-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Townsend, Belinda https://orcid.org/0000-0002-2480-2820
Funding

Funding for this research was provided by:

Australian National University College of Asia and the Pacific Asia-Pacific Innovation Program (N/A)
License Information

Text and Data Mining valid from 2021-07-08

Version of Record valid from 2021-07-08
More Information

Article History

Received: 11 February 2021

Accepted: 8 June 2021

First Online: 8 July 2021

Declarations

:

: Ethics approval for this study was received from The Australia National University Human Research Ethics Committee (Protocol 2019/326). All informants gave informed consent and were informed clearly about their freedom to opt out of the study at any point of time without providing justification for doing so.

: Not applicable.

: BT is a member of the Public Health Association of Australia and has represented the association on matters related to trade agreements and public health. She has received funding from various non-governmental organizations to attend speaking engagements related to trade agreements and health.

Document is current

Any future updates will be listed below